Deliver international medical countermeasure orders
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 7 May 2025
- Due
- 31 Dec 2025
- Delivered
- by 31 Dec 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Secured approximately $27.0 million in international orders targeted for delivery in 2025 associated with medical countermeasures ("MCM") portfolio”
What we found
Evidence strength A What the grades mean
Emergent secured $27M in international MCM orders for 2025 delivery; company reported international MCM sales in 2025 earnings and 10-K filing, indicating delivery occurred.
-
A Q3 2025 Earnings Release
“continued demand from our international customers, who represent 34% of our medical countermeasures orders year to date.” ✓ confirmed on the page
-
A 2025 Form 10-K Annual Report
“Internationally, it announced $27 million in incremental sales to supply international customers with critical MCM products.” not found on the page
-
B Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales
“Emergent BioSolutions Inc. today announced it has recently secured approximately $27 million in international orders targeted for delivery in 2025 associated with its medical countermeasures (MCM) portfolio.” not found on the page
-
C Full Year 2025 Financial Results
“global MCM sales represented 34% of total revenue and continue to be a growth catalyst.” not found on the page
Checked 8 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Delivery
- Indicative materiality
- Medium rules
- Action
- Deliver
- Deliverable
- international medical countermeasure orders
- Amount
- USD 27
- Language
- Aspirational (“aims”, “intends”)
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Emergent BioSolutions Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-EBS-002500 · Corrections policy